• 
  Lucie Sancey, François Lux, Shady Kotb, Stéphane Roux, Sandrine Dufort, et al.. The use of theranostic gadolinium-based nanoprobes to improve radiotherapy efficacy. British Journal of Radiology, British Institute of Radiology, 2014, 87 (1041), pp.20140134. ⟨10.1259/bjr.20140134⟩. ⟨hal-01053790⟩
• 
  Guillaume Vogin, Liza Hettal, Clarisse Bartau, Juliette Thariat, Marie-Virginie Claeys, et al.. Cranial organs at risk delineation: heterogenous practices in radiotherapy planning. Radiation Oncology, BioMed Central, 2021, 16, pp.26. ⟨10.1186/s13014-021-01756-y⟩. ⟨hal-03134498⟩
• 
  Caroline Even, Luis Sagaon Teyssier, Yoann Pointreau, Stéphane Temam, Florence Huguet, et al.. Factors associated with under-reporting of head and neck squamous cell carcinoma in cause-of-death records: A comparative study of two national databases in France from 2008 to 2012. PLoS ONE, Public Library of Science, 2021, 16 (2), pp.e0246252. ⟨10.1371/journal.pone.0246252⟩. ⟨hal-03131477⟩
• 
  Catherine Uzan, Chafika Mazouni, Caroline Rossoni, Brigitte de Korvin, Christine Tunon de Lara, et al.. Prospective Multicenter Study Validate a Prediction Model for Surgery Uptake Among Women with Atypical Breast Lesions. Annals of Surgical Oncology, Springer Verlag, 2020, ⟨10.1245/s10434-020-09107-z⟩. ⟨hal-03013819⟩
• 
  Christian Pfister, Valentin Harter, Yves Allory, François Radvanyi, Stéphane Culine, et al.. Design of a randomized controlled phase III study of dose dense methotrexate, vinblastine, doxorubicin and cisplatin (dd-MVAC) or gemcitabine and cisplatin (GC) as peri-operative chemotherapy for patients with locally advanced transitional cell cancer of the bladder. The French GETUG/AFU V05 VESPER trial. Contemporary Clinical Trials Communications, Elsevier, 2020, 17, pp.100536. ⟨10.1016/j.conctc.2020.100536⟩. ⟨hal-02909542⟩
• 
  Nicolas Gonzalo Núñez, Jimena Tosello Boari, Rodrigo Nalio Ramos, Wilfrid Richer, Nicolas Cagnard, et al.. Tumor invasion in draining lymph nodes is associated with Treg accumulation in breast cancer patients. Nature Communications, Nature Publishing Group, 2020, 11 (1), pp.3272. ⟨10.1038/s41467-020-17046-2⟩. ⟨inserm-02908210⟩
• 
  Sylvie Négrier, Nathalie Rioux-Leclercq, Céline Ferlay, Marine Gross-Goupil, Gwénaelle Gravis, et al.. Axitinib in first-line for patients with metastatic papillary renal cell carcinoma: Results of the multicentre, open-label, single-arm, phase II AXIPAP trial. European Journal of Cancer, Elsevier, 2020, 129, pp.107 - 116. ⟨10.1016/j.ejca.2020.02.001⟩. ⟨hal-02552562⟩
• 
  Manon Kissel, Isabelle Martel-Lafay, Justine Lequesne, Jean-Christophe Faivre, Cécile Le Péchoux, et al.. Stereotactic ablative radiotherapy and systemic treatments for extracerebral oligometastases, oligorecurrence, oligopersistence and oligoprogression from lung cancer. BMC Cancer, BioMed Central, 2019, 19 (1), pp.Article number: 1237. ⟨10.1186/s12885-019-6449-8⟩. ⟨hal-02478944⟩
• 
  Fatima Tensaouti, Anne Ducassou, Leonor Chaltiel, Stéphanie Bolle, Jean Louis Habrand, et al.. Feasibility of Dose Escalation in Patients With Intracranial Pediatric Ependymoma. Frontiers in Oncology, Frontiers, 2019, 9, pp.531. ⟨10.3389/fonc.2019.00531⟩. ⟨hal-02478956⟩
• 
  J.-Y. Blay, C. Honore, E. Stoeckle, P. Méeus, M. Jafari, et al.. Surgery in reference centers improves survival of sarcoma patients: a nationwide study. Annals of Oncology, Elsevier, 2019, Annals of oncology official journal of the European Society for Medical Oncology, 30 (7), pp.1143-1153. ⟨10.1093/annonc/mdz124⟩. ⟨hal-02509515⟩
• 
  Emmanuelle Bompas, Loïc Campion, Antoine Italiano, Axel Le Cesne, Christine Chevreau, et al.. Outcome of 449 adult patients with rhabdomyosarcoma: an observational ambispective nationwide study. Cancer Medicine, Wiley, 2018, Cancer medicine, 7 (8), pp.4023-4035. ⟨10.1002/cam4.1374⟩. ⟨hal-01978221⟩
• 
  Frédéric Chibon, Pauline Lagarde, Sebastien Salas, Gaëlle Pérot, Véronique Brouste, et al.. Validated prediction of clinical outcome in sarcomas and multiple types of cancer on the basis of a gene expression signature related to genome complexity. Nature Medicine, Nature Publishing Group, 2010, 16 (7), pp.781-787. ⟨10.1038/nm.2174⟩. ⟨inserm-02438669⟩
• 
  Elodie Girard, Séverine Eon‐marchais, Robert Olaso, Anne‐laure Renault, Francesca Damiola, et al.. Familial breast cancer and DNA repair genes: Insights into known and novel susceptibility genes from the GENESIS study, and implications for multigene panel testing. International Journal of Cancer, Wiley, 2019, 144 (8), pp.1962-1974. ⟨10.1002/ijc.31921⟩. ⟨inserm-02438452⟩
• 
  Mary Beth Terry, Yuyan Liao, Karin Kast, Antonis Antoniou, Jasmine Mcdonald, et al.. The Influence of Number and Timing of Pregnancies on Breast Cancer Risk for Women With BRCA1 or BRCA2 Mutations. JNCI Cancer Spectrum, Oxford University Press, 2018, 2 (4), pky078. ⟨10.1093/jncics/pky078⟩. ⟨inserm-02438434⟩
• 
  Elisé Kaboré, Charles Guenancia, Ines Vaz-Luis, Antonio Di Meglio, Barbara Pistilli, et al.. Association of body mass index and cardiotoxicity related to anthracyclines and trastuzumab in early breast cancer: French CANTO cohort study. PLoS Medicine, Public Library of Science, 2019, 16 (12), pp.e1002989. ⟨10.1371/journal.pmed.1002989⟩. ⟨inserm-02430330⟩
• 
  Suzy Scholl, Marina Popovic, Anne de la Rochefordiere, Elodie Girard, Sylvain Dureau, et al.. Clinical and genetic landscape of treatment naive cervical cancer: Alterations in PIK3CA and in epigenetic modulators associated with sub-optimal outcome. EBioMedicine, Elsevier, 2019, 43, pp.253-260. ⟨10.1016/j.ebiom.2019.03.069⟩. ⟨hal-02419801⟩
• 
  Yoan Ditchi, Chloé Broudin, Yolla El Dakdouki, Marie Muller, Pernelle Lavaud, et al.. Low risk of invasive lobular carcinoma of the breast in carriers of BRCA1 (hereditary breast and ovarian cancer) and TP53 (Li-Fraumeni syndrome) germline mutations. The Breast Journal, 2019, 25 (1), pp.16-19. ⟨10.1111/tbj.13154⟩. ⟨hal-02352242⟩
• 
  Elisabeth Luporsi, Jean-Pierre Bellocq, Jérôme Barriere, Julia Bonastre, Jérôme Chetritt, et al.. uPA/PAI-1, Oncotype DX™, MammaPrint®. Valeurs pronostique et prédictive pour une utilité clinique dans la prise en charge du cancer du sein. Bulletin du Cancer, John Libbey Eurotext, 2015, 102 (9), pp.719-729. ⟨10.1016/j.bulcan.2015.05.003⟩. ⟨inserm-02328397⟩
• 
  Alexandra Arfi, Delphine Hequet, Guillaume Bataillon, Carine Tran-Perennou, Fereshteh Farkhondeh, et al.. HPV DNA integration site as proof of the origin of ovarian metastasis from endocervical adenocarcinoma: three case reports. BMC Cancer, BioMed Central, 2019, 19 (1), pp.375. ⟨10.1186/s12885-019-5582-8⟩. ⟨inserm-02297426⟩
• 
  Christophe Le Tourneau, Maud Kamal, Olivier Trédan, Jean-Pierre Delord, Mario Campone, et al.. Designs and challenges for personalized medicine studies in oncology: focus on the SHIVA trial. Targeted Oncology, Springer Verlag (Germany), 2012, 7 (4), pp.253-265. ⟨10.1007/s11523-012-0237-6⟩. ⟨inserm-02294308⟩

53

154